Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research Proposal
NCT ID: NCT06977360
Last Updated: 2025-09-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2025-05-23
2025-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The specific objectives of this study are:
1. To develop a new iteration of an innovative smartphone-based self-care solution for patients with breast cancer undergoing chemotherapy (iCareBreast+);
2. To assess the feasibility and acceptability of iCareBreast+; and
3. To explore the preliminary effects of iCareBreast+ on the primary outcome of self-efficacy, and knowledge of breast cancer treatment, as well as secondary outcomes including anxiety, depression, health-related quality of life (HRQoL), social support and satisfaction with oncologic care.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Innovative Care-improvement Smartphone-based Perioperative Solution for Women Undergoing Breast Cancer Surgery
NCT04172350
A Pilot Tele-rehabilitation Trial for Breast Cancer Survivors
NCT04269967
Acceptability of 3D Printed Breast Models as Surgical Decision Aids for Breast Cancer Treatment
NCT04693364
Impact of a Breast cAncer Survivorship Interprofessional Community Care Model
NCT04660188
To Evaluate the Effectiveness and Safety of the Single-port Robotic-assisted Breast Surgery in Breast Cancer
NCT06561646
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Routine care
Routine care provided by NCCS
Intervention Group
Routine care + iCareBreast+ mobile app
Routine care provided by NCCS (identical to the control group) along with access to the iCareBreast+ mobile app
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Routine care
Routine care provided by NCCS
Routine care + iCareBreast+ mobile app
Routine care provided by NCCS (identical to the control group) along with access to the iCareBreast+ mobile app
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* are the age of 21 years old and above at the point of recruitment;
* are diagnosed with stage 1-3 breast cancer;
* will undergo chemotherapy first time (initiating or up to #4 cycles of chemo is acceptable);
* can speak, read and write in English or Mandarin; and
* has access to and able to use smart phone.
Exclusion Criteria
* are with a history of or concurrent other cancer types;
* have been suffering from psychiatric illness (e.g., schizophrenia), anxiety disorder or other mood disorder or impaired cognitive function;
* have alcohol or substance abuse within the previous year;
* are undergoing concurrent psychosocial interventions; and
* have been in the bereavement period in the last 6 months
* are in their pregnancy.
21 Years
100 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Buddy Healthcare Ltd OY
UNKNOWN
National Cancer Centre, Singapore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr Ryan Shea YC Tan, MBBS, MRCP(UK), MMed
Role: PRINCIPAL_INVESTIGATOR
National Cancer Centre, Singapore
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Cancer Centre, Singapore
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Dr Ryan Shea YC Tan, MBBS, MRCP(UK), MMed
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
iCareBreast+
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.